The University of Montreal Hospital Research Centre and the Canadian Research Initiative in Substance Misuse (CRISM), in collaboration with many Canadian partners, have launched the first-ever national clinical trial to study how patients respond to different treatments for prescription opioid use disorder, with the goal of improving treatment outcomes.
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have identified a promising solution to improving treatments offered to patients with cystic fibrosis.
This advancement, published in Frontiers in Cellular and Infection Microbiology, could lead to the development of new personalized therapies in the near future.
Anne Monette, postdoctoral fellow emerging from the Réjean Lapointe Immuno-Oncology laboratory (CRCHUM, University of Montreal and Montreal Cancer Institute), is embarking on a ground-breaking research project to identify cancer immunotherapy responders.
On December 15th, 2017, the CRCHUM Conferences invites John D. Rioux, professor of medicine at University of Montreal and Montreal Heart Institute, CRC in Genetics and Genomic Medicine. During this conference he will focus on the inflammatory bowel diseases such as Crohn’s Disease and ulcerative colitis.
On December 8th, 2017, the CRCHUM Conferences invites Lisa McKerracher, Founder and CEO, BioAxone BioSciences and Adjunct Professor, Department of Neurology and Neurosurgery at McGill University. During this conference she will review bed to bedside translation of their lead drug, a biologic drug to treat acute spinal cord injury.
The University of Montreal Hospital Research Centre (CRCHUM) has announced the appointment of Anne-Marie Mes-Masson as Associate Scientific Director of Basic and Translational Research.
On December 1st, 2017, the CRCHUM Conferences invites Jon McGavock, Associate Professor, Department of Pediatrics, Faculty of Health Sciences, University of Manitoba. He will discuss during his talk the current state of science with regards to prevent and management of type 2 diabetes and it’s complications and examine the translational work conducted.
The CRCHUM’s core facilities and services teams held their first annual Round-Table Meeting on November 9th. It was attended by some 60 technical managers, scientists and employees working in the core facilities and services, including the animal facility and the Institutional Animal Protection Committee (CIPA).
On November 27th, 2017, the CRCHUM Conferences invites Bernard Courtieu, Chairman and Chief Executive Officer at IntegraGen. He will discuss, recent progress in bio-informatics & genomic interpretation software tools.